Sanguinarine protects against osteoarthritis by suppressing the expression of catabolic proteases

Oncotarget

Volumn 8, Issue 38, 2017, Pages 62900-62913

  Ma, Yan ^a,b   Sun, Xuewu ^a,b   Huang, Kangmao ^a,b   Shen, Shuying ^b   Lin, Xianfeng ^a,b   Xie, Ziang ^a,b   Wang, Jiying ^b   Fan, Shunwu ^a,b   Ma, Jianjun ^a,b   Zhao, Xing ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b Key Laboratory of Biotherapy of Zhejiang Province   (China)

Author keywords

Catabolic proteases; Chondrocyte; Osteoarthritis; Sanguinarine

Indexed keywords

A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIF 5; COLLAGENASE 3; DISINTEGRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; METALLOPROTEINASE; PROTEINASE; SANGUINARINE; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT INJURY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARTILAGE MATRIX; CHONDROCYTE; CONTROLLED STUDY; DRUG MECHANISM; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IC50; IN VITRO STUDY; IN VIVO STUDY; KNEE MENISCUS; MALE; MOUSE; NONHUMAN; OSTEOARTHRITIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 85028308563     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.17036     Document Type: Article

References (38)

1. UK NCGC. Osteoarthritis: Care and Management in Adults. (London: National Institute for Health and Care Excellence), 2014
2. Hauk L. Treatment of knee osteoarthritis: a clinical practice guideline from the AAOS. Am Fam Physician. 2014; 89:918-920
3. Haq SA, Davatchi F, Dahaghin S, Islam N, Ghose A, Darmawan J, Chopra A, Yu ZQ, Dans LF, Rasker JJ. Development of a questionnaire for identification of the risk factors for osteoarthritis of the knees in developing countries. A pilot study in Iran and Bangladesh. An ILAR-COPCORD phase III study. Int J Rheum Dis. 2010; 13:203-214
4. Dahaghin S, Tehrani-Banihashemi SA, Faezi ST, Jamshidi AR, Davatchi F. Squatting, sitting on the floor, or cycling: are life-long daily activities risk factors for clinical knee osteoarthritis? Stage III results of a community-based study. Arthritis Rheum. 2009; 61:1337-1342
5. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011; 7:33-42
6. Conaghan PG. Osteoarthritis in 2012: parallel evolution of OA phenotypes and therapies. Nat Rev Rheumatol. 2013; 9:68-70
7. Liao S, Zhou K, Li D, Xie X, Jun F, Wang J. Schisantherin A suppresses interleukin-1beta-induced inflammation in human chondrocytes via inhibition of NF-kappaB and MAPKs activation. Eur J Pharmacol. 2016; 780:65-70
8. Wang D, Qiao J, Zhao X, Chen T, Guan D. Thymoquinone inhibits IL-1β-induced inflammation in human osteoarthritis chondrocytes by suppressing NF-κB and MAPKs signaling pathway. Inflammation. 2015; 38:2235-2241
9. Piao T, Ma Z, Li X, Liu J. Taraxasterol inhibits IL-1betainduced inflammatory response in human osteoarthritic chondrocytes. Eur J Pharmacol. 2015; 756:38-42
10. Ma Z, Piao T, Wang Y, Liu J. Astragalin inhibits IL-1betainduced inflammatory mediators production in human osteoarthritis chondrocyte by inhibiting NF-kappaB and MAPK activation. Int Immunopharmacol. 2015; 25:83-87
11. Kong P, Chen G, Jiang A, Wang Y, Song C, Zhuang J, Xi C, Wang G, Ji Y, Yan J. Sesamin inhibits IL-1β-stimulated inflammatory response in human osteoarthritis chondrocytes by activating Nrf2 signaling pathway. Oncotarget. 2016; 7:83720-83726. doi: 10.18632/oncotarget.13360
12. Chen P, Xia C, Mei S, Wang J, Shan Z, Lin X, Fan S. Intra-articular delivery of sinomenium encapsulated by chitosan microspheres and photo-crosslinked GelMA hydrogel ameliorates osteoarthritis by effectively regulating autophagy. Biomaterials. 2016; 81:1-13
13. Xia C, Chen P, Mei S, Ning L, Lei C, Wang J, Zhang J, Ma J, Fan S. Photo-crosslinked HAMA hydrogel with cordycepin encapsulated chitosan microspheres for osteoarthritis treatment. Oncotarget. 2017; 8:2835-2849. doi: 10.18632/oncotarget.13748
14. Ma J, Ma Y, Liu X, Chen S, Liu C, Qin A, Fan S. Gambogic acid inhibits osteoclast formation and ovariectomyinduced osteoporosis by suppressing the JNK, p38 and Akt signalling pathways. Biochem J. 2015; 469:399-408
15. Grenby TH. The use of sanguinarine in mouthwashes and toothpaste compared with some other antimicrobial agents. Br Dent J. 1995; 178:254-258
16. Singh CK, Kaur S, George J, Nihal M, Pellitteri HM, Scarlett CO, Ahmad N. Molecular signatures of sanguinarine in human pancreatic cancer cells: a large scale label-free comparative proteomics approach. Oncotarget. 2015; 6:10335-10348. doi: 10.18632/oncotarget.3231
17. Mackraj I, Govender T, Gathiram P. Sanguinarine. Cardiovasc Ther. 2008; 26:75-83
18. Li H, Zhai Z, Liu G, Tang T, Lin Z, Zheng M, Qin A, Dai K. Sanguinarine inhibits osteoclast formation and bone resorption via suppressing RANKL-induced activation of NF-kappaB and ERK signaling pathways. Biochem Biophys Res Commun. 2013; 430:951-956
19. Godowski KC. Antimicrobial action of sanguinarine. J Clin Dent. 1989; 1:96-101
20. Mitscher LA, Drake S, Gollapudi SR, Okwute SK. A modern look at folkloric use of anti-infective agents. J Nat Prod. 1987; 50:1025-1040
21. Li W, Li H, Mu Q, Zhang H, Yao H, Li J, Niu X. Protective effect of sanguinarine on LPS-induced endotoxic shock in mice and its effect on LPS-induced COX-2 expression and COX-2 associated PGE2 release from peritoneal macrophages. Int Immunopharmacol. 2014; 22:311-317
22. Niu X, Fan T, Li W, Huang H, Zhang Y, Xing W. Protective effect of sanguinarine against acetic acid-induced ulcerative colitis in mice. Toxicol Appl Pharmacol. 2013; 267:256-265
23. Ozawa M, Nishida K, Yoshida A, Saito T, Harada R, Machida T, Ozaki T. Hyaluronan suppresses mechanical stress-induced expression of catabolic enzymes by human chondrocytes via inhibition of IL-1β production and subsequent NF-κB activation. Inflamm Res. 2015; 64:243-252
24. Kato T, Miyaki S, Ishitobi H, Nakamura Y, Nakasa T, Lotz MK, Ochi M. Exosomes from IL-1β stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes. Arthritis Res Ther. 2014; 16:R163
25. Clark IM, Parker AE. Metalloproteinases: their role in arthritis and potential as therapeutic targets. Expert Opin Ther Targets. 2003; 7:19-34
26. Glasson SS, Askew R, Sheppard B, Carito B, Blanchet T, Ma HL, Flannery CR, Peluso D, Kanki K, Yang Z, Majumdar MK, Morris EA. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature. 2005; 434:644-648
27. Stanton H, Rogerson FM, East CJ, Golub SB, Lawlor KE, Meeker CT, Little CB, Last K, Farmer PJ, Campbell IK, Fourie AM, Fosang AJ. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature. 2005; 434:648-652
28. Huang C, Liao G, Han J, Zhang G, Zou B. Edaravone suppresses degradation of type II collagen. Biochem Biophys Res Commun. 2016; 473:840-844
29. Vincenti MP, Brinckerhoff CE. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 2002; 4:157-164
30. Roman-Blas JA, Jimenez SA. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage. 2006; 14:839-848
31. Ghosh M, Aguirre V, Wai K, Felfly H, Dietrich WD, Pearse DD. The interplay between cyclic AMP, MAPK, and NF-kappaB pathways in response to proinflammatory signals in microglia. Biomed Res Int. 2015; 2015:308461
32. Yang S, Kim J, Ryu JH, Oh H, Chun CH, Kim BJ, Min BH, Chun JS. Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med. 2010; 16:687-693
33. Ismail HM, Yamamoto K, Vincent TL, Nagase H, Troeberg L, Saklatvala J. Interleukin-1 acts via the JNK-2 signaling pathway to induce aggrecan degradation by human chondrocytes. Arthritis Rheumatol. 2015; 67:1826-1836
34. Chaturvedi MM, Kumar A, Darnay BG, Chainy GB, Agarwal S, Aggarwal BB. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation. J Biol Chem. 1997; 272:30129-30134
35. Niu X, Fan T, Li W, Xing W, Huang H. The antiinflammatory effects of sanguinarine and its modulation of inflammatory mediators from peritoneal macrophages. Eur J Pharmacol. 2012; 689:262-269
36. Gosset M, Berenbaum F, Thirion S, Jacques C. Primary culture and phenotyping of murine chondrocytes. Nat Protoc. 2008; 3:1253-1260
37. Galois L, Etienne S, Grossin L, Watrin-Pinzano A, Cournil-Henrionnet C, Loeuille D, Netter P, Mainard D, Gillet P. Dose-response relationship for exercise on severity of experimental osteoarthritis in rats: a pilot study. Osteoarthritis Cartilage. 2004; 12:779-786
38. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, Salter D, van den Berg WB. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage. 2006; 14:13-29